GENE THERAPY - EVOLVED
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Oct 2025)
What this means for you
This application is over — abandoned 01 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90517606
- Mark type
- Stylized text
- Filed
- 08 Feb 2021
- Published for opposition
- 19 Oct 2021
- Abandoned
- 01 Oct 2025
- Attorney of record
- Rachelle A. Dubow, Esq.
Goods and services
- Class 042 — Scientific and technological services: Scientific and laboratory research services in the fields of gene, genome and cellular editing, modification, engineering and regulation for use in developing human and veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, and drug discovery and development
Owner
- Saliogen Therapeutics, Inc., Lexington, MA, US
- Saliogen Therapeutics, Inc., Burlington, MA, US
Prosecution history
- 01 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Jun 2024 — SOU EXTENSION 5 GRANTED
- 04 Jun 2024 — SOU EXTENSION 5 FILED
- 04 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 28 Feb 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Feb 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 28 Feb 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Dec 2023 — SOU EXTENSION 4 GRANTED
- 04 Dec 2023 — SOU EXTENSION 4 FILED
- 15 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jun 2023 — SOU EXTENSION 3 GRANTED
- 13 Jun 2023 — SOU EXTENSION 3 FILED